Discovery of clinical candidate Sivopixant (S-600918): Lead optimization of dioxotriazine derivatives as selective P2X3 receptor antagonists

Hiroyuki Kai, Noriyuki Kurose, Takayuki Kameyma et al.|Bioorganic & Medicinal Chemistry Letters|2021

Cited by 28